Quidel | QDEL - Cash And Equivalent


Quidel reported $98.1M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 1.05B 116M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Quidel USD 98.1M 53.6M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 459.12M 91.9M Sep/2025